Table of contents

Food allergy

What's new

Updated 2023 EAACI guidelines for the diagnosis of IgE-mediated food allergy.



Food allergy is an adverse food-stimulated immune response initiated on exposure to a given food.
Food allergy is mostly caused by IgE-mediated antibodies (type 1 or early; 48%) and IgE-independent immune response including type IV (18%), type III (10%), and type II (6%) to specific foods (milk, eggs, wheat, fish, soy, peanuts, fish, shellfish, cherries, peaches, plums, apricots, nuts, and seeds) influenced by genetic and environmental (improved hygiene, lifestyle, diet and nutrition) factors.
The prevalence of IgE-mediated food allergy in the US is estimated at 10,000 in 100,000 adults.
Disease course
Clinical manifestations of an immediate reaction include anaphylactic shock, urticaria, and angioedema. Late reaction food reaction symptoms include fatigue, irritability, depression, hyperactivity, insomnia, headache, poor concentration, paleness, itching limbs, involuntary bedwetting, asthma, colds, indigestion, colic, diarrhea, bloating, and skin lesions. The disease impairs QoL necessitating lifelong prevention of the specific food.
Prognosis and risk of recurrence
The mortality risk associated with fatal anaphylaxis is < 1%.


Key sources

The following summarized guidelines for the evaluation and management of food allergy are prepared by our editorial team based on guidelines from the American Academy of Allergy, Asthma & Immunology (AAAAI 2024,2020), the World Allergy Organization (WAO 2024), the American Academy of Family Physicians (AAFP 2023), the European Academy of Allergy and Clinical Immunology (EAACI 2023,2021,2018,2014), the European Society for ...
Show more

Diagnostic investigations

Medical history: as per EAACI 2023 guidelines, elicit a detailed allergy-focused clinical history as the first step of the diagnostic evaluation in patients with suspected IgE-mediated food allergy.
Create free account

More topics in this section

  • Specific allergy testing

  • Serum IgE (general indications)

  • Serum IgE (severe eczema)

  • Serum IgE (alpha-gal syndrome)

  • Component-resolved diagnostic tests

  • Oral food challenge

  • Other tests

Medical management

As per EAACI 2014 guidelines:
Consider administering antihistamines in adult and pediatric patients with acute non-life-threatening symptoms from food allergy.
Do not use antihistamines
or mast cell stabilizers as prophylactic therapy.

More topics in this section

  • Epinephrine autoinjectors

  • Corticosteroid autoinjectors

  • Specific immunotherapy (indications, children)

  • Specific immunotherapy (indications, adults)

  • Specific immunotherapy (monitoring)

  • Biological therapies

Nonpharmacologic interventions

Elimination diets: as per GA²LEN 2022 guidelines, consider advising avoidance of the offending food in patients with documented food allergy unless individual circumstances and risks allow for some consumption, as advised by their healthcare professional. Consider advising to continue the intake of the offending food in most breastfeeding mothers having infants with a food allergy; consider advising avoidance in rare cases.

More topics in this section

  • Probiotics

Specific circumstances

Patients with coexisting asthma: as per GA²LEN 2022 guidelines, optimize asthma control in patients with food allergies to reduce morbidity and mortality due to asthma.

More topics in this section

  • Patients with cow's milk allergy (evaluation)

  • Patients with cow's milk allergy (hydrolyzed formulas)

  • Patients with cow's milk allergy (immunotherapy)

  • Patients with peanut allergy

  • Patients with egg allergy

Patient education

General counseling: as per AAAAI 2024 guidelines, educate patients on avoidance of potential exposure to their allergens.
Show 3 more

Preventative measures

Early introduction of foods
As per AAFP 2023 guidelines:
Introduce peanuts, cow's milk, wheat, and cooked eggs early at 4-6 months of age to reduce the risk of developing food allergies.
Introduce peanuts and cooked eggs early at 4-6 months of age to reduce the risk of developing food allergies in high-risk infants.

More topics in this section

  • Hydrolyzed formulas

  • Measures with no evidence for benefit

Follow-up and surveillance

Indications for specialist referral: as per EAACI 2014 guidelines, refer patients with eosinophilic esophagitis to an allergist/immunologist for diagnostic evaluation.

More topics in this section

  • Assessment of treatment response

  • Serial clinical assessment

Quality improvement

School policies: as per BSACI 2017 guidelines, ensure that all staff within the school and early years setting receive appropriate training in managing an allergic reaction.
Show 2 more

More topics in this section

  • Restaurant policies